Efavirenz
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4763 publications
Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.
Journal: ACS infectious diseases
Published: June 01, 2026
Determination of free fraction (fu) of compounds by flux dialysis using the rapid equilibrium dialysis (RED) device: establishing empirical permeability for rapid estimation.
Journal: Xenobiotica; the fate of foreign compounds in biological systems
Published: April 28, 2026
Efavirenz-Altered Gut-Microbiota, Tph1, and Systemic 5-HT Levels: Could They Affect Depression Mechanisms in Mice?
Journal: International journal of molecular sciences
Published: April 12, 2026
Efavirenz 400 mg vs. 600 mg Combined with Lamivudine and Tenofovir in Treatment-Naïve HIV-Infected Patients in China: A Randomized, Multi-Centered, Controlled Trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 08, 2026
AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design.
Journal: Journal of chemical information and modeling
Published: March 27, 2026
HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya.
Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026
Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.
Journal: The Journal of the Association of Physicians of India
Published: March 12, 2026
Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV.
Journal: Journal of the International Association of Providers of AIDS Care
Published: March 10, 2026
Physiologically Based Pharmacokinetic Modeling to Assess Antiretroviral-BTK Inhibitor Interactions and Provide Recommendations for Co-Administration Regimens.
Journal: Pharmaceutics
Published: March 02, 2026
Longitudinal analysis of viral suppression before, during, and after pregnancy among women on antiretroviral therapy in Uganda: six-year real-world experience.
Journal: HIV research & clinical practice
Published: February 28, 2026
CYP46A1 activation by low-dose efavirenz uncovers the link between brain cholesterol metabolism, energetics, and vasculature.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 28, 2026
The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants.
Journal: Clinical and translational science
Published: February 24, 2026
Last Updated: 06/30/2026